Illustration of HIV cells

Medicine’s Rafick-Pierre Sékaly speaks on new HIV treatment study

Selective suppression of inflammation could deplete HIV and control HIV activation

Science Magazine: Rafick-Pierre Sékaly, the Richard J. Fasenmyer Professor of Immunopathogenesis and co-director of the Center for AIDS Research Proteomics and Systems Biology Core, spoke about a new study on how FDA-approved drugs for rheumatoid arthritis may help patients with HIV. Sékaly also is a professor of pathology.